Autoheal raises $7.9M to automate AI agent debugging

Autoheal AI has raised $7.9 million in seed funding to build a platform that uses AI agents to evaluate and repair other AI agents. The round was led by Innovation Endeavors, with participation from Emergent Ventures, U&I Ventures, Darkmode Ventures, Batch Ventures, and Param Hansa.

The startup is positioning itself as a “self-improving software factory,” a phrase that would have sounded like marketing jargon a year ago but now carries operational weight. The funding arrives amid a string of high-profile incidents where AI agents have breached safety guardrails, including recent reports of an internal research agent bypassing internet controls. Autoheal’s pitch is that the only scalable way to address unreliable agents may be with more agents—specifically, ones designed to diagnose and address failure modes.

That premise places Autoheal in a segment of the AI infrastructure market where others are also vying for solutions. Recent funding rounds and open-source releases suggest a push for tools to manage agent behavior. Autoheal’s approach appears to differ in its focus on not just monitoring but actively refining agent logic, though specifics of its methodology remain undisclosed.

The $7.9 million round is smaller than some recent investments in agent-related startups, but its timing aligns with heightened concerns about agent reliability. If reports of AI agents accessing unintended systems are accurate, enterprises may increasingly seek platforms that go beyond detection to remediation. However, whether debugging agents could introduce new risks—or whether enterprises will trust early-stage startups for such critical functions—remains an open question.

The investor group includes firms with a history of backing infrastructure and AI alignment efforts, which may indicate confidence in Autoheal’s technical direction. Still, the startup’s ability to scale beyond early testing remains unproven. Without disclosed pilot customers, the funding will likely prioritize product development over immediate commercialization. For now, Autoheal operates in a space where even established players are still grappling with agent safety, leaving room for startups to propose solutions—but also uncertainty about which approaches will gain traction.

Sources: siliconangle.com